BD (BDX) announced that the company’s Board of Directors has set the close of business on February 5 as the record date for the previously announced spin-off of BD’s Biosciences & Diagnostic Solutions business to BD’s shareholders. Immediately following the spin-off, the spun-off entity will be combined with Waters Corporation (WAT) in a Reverse Morris Trust transaction. The combination is expected to be completed on February 9, subject to the satisfaction of customary closing conditions.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BDX: